![]() |
||||
|
||||
|
|
||||
Re: Maternal deaths, and risk of misoprostol for missed ABFrom: Gerald P. Rodríguez (geraldpr@cybermesa.com)Sat Mar 18 11:15:06 2006
Today's Wall Street Journal reports that Planned Parenthood in Washington DC said yesterday that it was changing its prescribing practices for the use of MIFEPRISTONE (Mifprex) (RU-486) in light of two recent maternal deaths associated with its use vaginally instead of orally. Its vaginal use is off-label and this practice is now being implicated in the death of 6 total patients from sepsis. Gerald P. Rodríguez, M.D., FACOG Santa Fe ~~~~~~~~~~~~~ Quien calla otorga. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
>----- Original Message -----
> In light of the recent news linking maternal deaths to use of vaginal
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:02:24 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.